Shagun Singh
Stock Analyst at RBC Capital
(2.46)
# 1,478
Out of 4,496 analysts
136
Total ratings
46.28%
Success rate
-0.47%
Average return
Main Sectors:
17 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| JNJ Johnson & Johnson | Reiterates: Outperform | $175 | $154.69 | +13.13% | 11 | Jul 18, 2024 | |
| MDT Medtronic | Reiterates: Sector Perform | $92 | $79.48 | +15.75% | 14 | Jul 17, 2024 | |
| OM Outset Medical | Upgrades: Outperform | $5 → $6 | $3.87 | +55.04% | 7 | Jun 21, 2024 | |
| ZYXI Zynex | Reiterates: Outperform | $15 | $10.10 | +48.51% | 3 | Jun 14, 2024 | |
| ABT Abbott Laboratories | Reiterates: Outperform | $125 | $102.03 | +22.51% | 9 | Jun 4, 2024 | |
| BSX Boston Scientific | Maintains: Outperform | $78 → $82 | $77.56 | +5.72% | 10 | Apr 25, 2024 | |
| INSP Inspire Medical Systems | Initiates: Outperform | $285 | $143.74 | +98.27% | 1 | Apr 19, 2024 | |
| SYK Stryker | Maintains: Outperform | $360 → $386 | $340.95 | +13.21% | 13 | Apr 15, 2024 | |
| NVRO Nevro | Maintains: Sector Perform | $18 → $16 | $9.10 | +75.82% | 7 | Apr 15, 2024 | |
| EW Edwards Lifesciences | Maintains: Outperform | $95 → $101 | $86.50 | +16.76% | 13 | Apr 15, 2024 | |
| DXCM DexCom | Initiates: Outperform | $165 | $111.66 | +47.77% | 1 | Mar 12, 2024 | |
| AXNX Axonics | Reiterates: Sector Perform | $71 | $67.72 | +4.84% | 5 | Feb 29, 2024 | |
| TFX Teleflex | Maintains: Outperform | $272 → $265 | $221.79 | +19.48% | 15 | Feb 23, 2024 | |
| PEN Penumbra | Reiterates: Outperform | $289 | $189.87 | +52.21% | 7 | Feb 23, 2024 | |
| ZBH Zimmer Biomet Holdings | Reiterates: Outperform | $140 | $110.50 | +26.70% | 8 | Feb 9, 2024 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $400 → $432 | $455.01 | -5.06% | 10 | Jan 24, 2024 | |
| GMED Globus Medical | Reiterates: Outperform | $70 | $72.63 | -3.62% | 2 | Jan 11, 2024 |
Johnson & Johnson
Jul 18, 2024
Reiterates: Outperform
Price Target: $175
Current: $154.69
Upside: +13.13%
Medtronic
Jul 17, 2024
Reiterates: Sector Perform
Price Target: $92
Current: $79.48
Upside: +15.75%
Outset Medical
Jun 21, 2024
Upgrades: Outperform
Price Target: $5 → $6
Current: $3.87
Upside: +55.04%
Zynex
Jun 14, 2024
Reiterates: Outperform
Price Target: $15
Current: $10.10
Upside: +48.51%
Abbott Laboratories
Jun 4, 2024
Reiterates: Outperform
Price Target: $125
Current: $102.03
Upside: +22.51%
Boston Scientific
Apr 25, 2024
Maintains: Outperform
Price Target: $78 → $82
Current: $77.56
Upside: +5.72%
Inspire Medical Systems
Apr 19, 2024
Initiates: Outperform
Price Target: $285
Current: $143.74
Upside: +98.27%
Stryker
Apr 15, 2024
Maintains: Outperform
Price Target: $360 → $386
Current: $340.95
Upside: +13.21%
Nevro
Apr 15, 2024
Maintains: Sector Perform
Price Target: $18 → $16
Current: $9.10
Upside: +75.82%
Edwards Lifesciences
Apr 15, 2024
Maintains: Outperform
Price Target: $95 → $101
Current: $86.50
Upside: +16.76%
DexCom
Mar 12, 2024
Initiates: Outperform
Price Target: $165
Current: $111.66
Upside: +47.77%
Axonics
Feb 29, 2024
Reiterates: Sector Perform
Price Target: $71
Current: $67.72
Upside: +4.84%
Teleflex
Feb 23, 2024
Maintains: Outperform
Price Target: $272 → $265
Current: $221.79
Upside: +19.48%
Penumbra
Feb 23, 2024
Reiterates: Outperform
Price Target: $289
Current: $189.87
Upside: +52.21%
Zimmer Biomet Holdings
Feb 9, 2024
Reiterates: Outperform
Price Target: $140
Current: $110.50
Upside: +26.70%
Intuitive Surgical
Jan 24, 2024
Maintains: Outperform
Price Target: $400 → $432
Current: $455.01
Upside: -5.06%
Globus Medical
Jan 11, 2024
Reiterates: Outperform
Price Target: $70
Current: $72.63
Upside: -3.62%